• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血标志物在结直肠癌患者中的预后价值:一项前瞻性研究。

Prognostic value of coagulation markers in patients with colorectal caner: A prospective study.

作者信息

Chen Wenxin, Li Yueying, Wang Weifeng, Xue Yingjun, Qian Jianxin, Liu Weiwei, Hu Xiaobo

机构信息

Department of Laboratory Medicine, Longhua Hospital Shanghai University of Traditional Chinese Medicine Shanghai China.

Department of Laboratory Medicine and Central Laboratory, Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai China.

出版信息

Health Sci Rep. 2024 Jan 31;7(2):e1553. doi: 10.1002/hsr2.1553. eCollection 2024 Feb.

DOI:10.1002/hsr2.1553
PMID:38304067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10831132/
Abstract

BACKGROUND AND AIMS

The occurrence, growth, and metastasis of colorectal cancer (CRC) are connected to the hypercoagulable state of blood (CRC). This study aimed to identify significant coagulation factors to predict metastasis and prognosis of CRC.

METHODS

Thrombomodulin (TM), thrombin-antithrombin complex (TAT), α2-plasmininhibitor-plasmin complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) were detected by chemiluminescence immunoassay using Sysmex HISCL5000 automated analyzers. The Sysmex CS 5100 automatic blood coagulation analyzer was used to detect d-dimer (DD), fibrin degradation product (FDP), prothrombin time (PT), thrombin time (TT), international normalized ratio (INR), fibrinogen (Fbg), and activated partial thromboplastin time (APTT). Area under the curve (AUC) and the receiver operating characteristic curve (ROC) were used to assess the diagnostic efficacy of markers. Kaplan-Meier analysis was used to calculate survival probabilities. Independent prognostic factors and the nomogram were developed using single-factor and multifactor cox regression analysis model.

RESULTS

The following indicators (TM, TAT, PIC, t-PAIC, DD, FDP, PT, INR, APTT, and Fbg) were markedly higher in CRC patients than in healthy controls, and they were higher in the metastasis (M) group than in the nonmetastasis (NM) group. The combination "TAT + PIC + DD + FDP + Fbg" can distinguish M from NM with exceptional sensitivity and specificity. Patients with CRC who had high levels of TAT, PIC, DD, FDP, Fbg, TM, tPAIC, PT, and INR had significantly shorter survival.

CONCLUSION

The prognosis of CRC patients can be predicted by coagulation indicators. The independent predictive variables for overall survival were found to be TM and DD. To forecast CRC patient survival, a nomogram was created.

摘要

背景与目的

结直肠癌(CRC)的发生、生长和转移与血液的高凝状态有关。本研究旨在确定预测CRC转移和预后的重要凝血因子。

方法

采用Sysmex HISCL5000自动分析仪通过化学发光免疫分析法检测血栓调节蛋白(TM)、凝血酶 - 抗凝血酶复合物(TAT)、α2 - 纤溶酶抑制物 - 纤溶酶复合物(PIC)和组织纤溶酶原激活物 - 抑制物复合物(t - PAIC)。使用Sysmex CS 5100自动凝血分析仪检测D - 二聚体(DD)、纤维蛋白降解产物(FDP)、凝血酶原时间(PT)、凝血酶时间(TT)、国际标准化比值(INR)、纤维蛋白原(Fbg)和活化部分凝血活酶时间(APTT)。曲线下面积(AUC)和受试者工作特征曲线(ROC)用于评估标志物的诊断效能。采用Kaplan - Meier分析计算生存概率。使用单因素和多因素cox回归分析模型确定独立预后因素并绘制列线图。

结果

CRC患者的以下指标(TM、TAT、PIC、t - PAIC、DD、FDP、PT、INR、APTT和Fbg)明显高于健康对照组,且转移(M)组高于非转移(NM)组。“TAT + PIC + DD + FDP + Fbg”组合能够以极高的敏感性和特异性区分M组和NM组。TAT、PIC、DD、FDP、Fbg、TM、tPAIC、PT和INR水平高的CRC患者生存时间明显较短。

结论

凝血指标可预测CRC患者的预后。发现总体生存的独立预测变量为TM和DD。为预测CRC患者的生存情况,绘制了列线图。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2317/10831132/091c94f5175d/HSR2-7-e1553-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2317/10831132/a81851fcf498/HSR2-7-e1553-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2317/10831132/b3f164b48892/HSR2-7-e1553-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2317/10831132/436ddeb6c33f/HSR2-7-e1553-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2317/10831132/75ea0a25cc52/HSR2-7-e1553-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2317/10831132/091c94f5175d/HSR2-7-e1553-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2317/10831132/a81851fcf498/HSR2-7-e1553-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2317/10831132/b3f164b48892/HSR2-7-e1553-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2317/10831132/436ddeb6c33f/HSR2-7-e1553-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2317/10831132/75ea0a25cc52/HSR2-7-e1553-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2317/10831132/091c94f5175d/HSR2-7-e1553-g004.jpg

相似文献

1
Prognostic value of coagulation markers in patients with colorectal caner: A prospective study.凝血标志物在结直肠癌患者中的预后价值:一项前瞻性研究。
Health Sci Rep. 2024 Jan 31;7(2):e1553. doi: 10.1002/hsr2.1553. eCollection 2024 Feb.
2
Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.凝血酶-抗凝血酶复合物、纤溶酶-α2纤溶酶抑制物复合物、血栓调节蛋白及纤溶酶原激活物抑制物-1在恶性肿瘤合并静脉血栓患者中的诊断及预后价值
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620971041. doi: 10.1177/1076029620971041.
3
The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms.TAT、PIC、TM 和 t-PAIC 在 BCR/ABL 阴性骨髓增殖性肿瘤血管事件中的临床意义。
Clin Exp Med. 2024 May 22;24(1):107. doi: 10.1007/s10238-024-01371-7.
4
The values of coagulation function in COVID-19 patients.新型冠状病毒肺炎患者凝血功能的变化。
PLoS One. 2020 Oct 29;15(10):e0241329. doi: 10.1371/journal.pone.0241329. eCollection 2020.
5
Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study.血栓调节蛋白(TM)、凝血酶 - 抗凝血酶复合物(TAT)、纤溶酶 - α2 - 纤溶酶抑制剂复合物(PIC)以及组织型纤溶酶原激活物 - 抑制剂复合物(t - PAIC)在产后出血中纤溶活性的评估:一项回顾性比较队列研究。
Ann Transl Med. 2022 Dec;10(23):1273. doi: 10.21037/atm-22-5221.
6
[Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome].[四种新型血栓标志物联合传统凝血检测对抗磷脂综合征血栓形成的预测价值]
Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Dec 18;55(6):1033-1038. doi: 10.19723/j.issn.1671-167X.2023.06.012.
7
Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.组织型纤溶酶原激活物抑制剂复合物化学发光法的建立及其在胃癌中的应用。
BMC Biotechnol. 2024 May 8;24(1):30. doi: 10.1186/s12896-024-00850-9.
8
Predictive value of thrombin-antithrombin III complex and tissue plasminogen activator-inhibitor complex biomarkers in assessing the severity of early-stage acute pancreatitis.凝血酶-抗凝血酶 III 复合物和组织型纤溶酶原激活物-抑制剂复合物生物标志物在评估早期急性胰腺炎严重程度中的预测价值。
J Gastroenterol Hepatol. 2024 Oct;39(10):2088-2096. doi: 10.1111/jgh.16641. Epub 2024 Jun 1.
9
Value of novel thrombotic markers for predicting occurrence of the malignant cerebral artery infarction: a prospective clinical study.新型血栓形成标志物对预测恶性大脑动脉梗死发生的价值:一项前瞻性临床研究。
Front Neurol. 2023 Nov 30;14:1238742. doi: 10.3389/fneur.2023.1238742. eCollection 2023.
10
Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.评估 TAT、PIC、tPAIC 和 sTM 在弥散性血管内凝血中的联合诊断价值:一项多中心前瞻性观察研究。
Thromb Res. 2019 Jan;173:20-26. doi: 10.1016/j.thromres.2018.11.010. Epub 2018 Nov 13.

引用本文的文献

1
Coagulation markers as independent predictors of colorectal cancer aggressiveness.凝血标志物作为结直肠癌侵袭性的独立预测指标。
BMC Gastroenterol. 2025 Sep 2;25(1):634. doi: 10.1186/s12876-025-04249-4.
2
Extent of peritoneal metastases from colorectal cancer is not associated with changes in thrombin generation or fibrinolysis.结直肠癌腹膜转移的范围与凝血酶生成或纤维蛋白溶解的变化无关。
Pleura Peritoneum. 2024 Nov 6;9(4):149-154. doi: 10.1515/pp-2024-0009. eCollection 2024 Dec.

本文引用的文献

1
Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.不明原因静脉血栓栓塞症(VTE)患者中,检测癌症对癌症或静脉血栓栓塞症(VTE)相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2021 Oct 1;10(10):CD010837. doi: 10.1002/14651858.CD010837.pub5.
2
Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.凝血酶-抗凝血酶复合物、纤溶酶-α2纤溶酶抑制物复合物、血栓调节蛋白及纤溶酶原激活物抑制物-1在恶性肿瘤合并静脉血栓患者中的诊断及预后价值
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620971041. doi: 10.1177/1076029620971041.
3
Biomarkers versus viscoelastic testing for the detection of fibrinolysis.
用于检测纤维蛋白溶解的生物标志物与粘弹性测试
ANZ J Surg. 2020 Apr;90(4):411-412. doi: 10.1111/ans.15649.
4
Monitoring of fibrinolytic system activity with plasminogen, D-dimers and FDP in primary total knee arthroplasty (TKA) after topical, intravenous or combined administration of tranexamic acid.局部、静脉或联合应用氨甲环酸后初次全膝关节置换术(TKA)中纤溶系统活性的监测:纤溶酶原、D-二聚体和 FDP。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Jun;164(2):168-176. doi: 10.5507/bp.2019.034. Epub 2019 Sep 16.
5
Transurethral resection versus holmium laser enucleation of the prostate: A prospective randomized trial comparing perioperative thrombin generation and fibrinolysis.经尿道前列腺切除术与钬激光剜除术:一项比较围手术期凝血酶生成和纤维蛋白溶解的前瞻性随机试验。
Medicine (Baltimore). 2019 Apr;98(15):e15223. doi: 10.1097/MD.0000000000015223.
6
Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.评估 TAT、PIC、tPAIC 和 sTM 在弥散性血管内凝血中的联合诊断价值:一项多中心前瞻性观察研究。
Thromb Res. 2019 Jan;173:20-26. doi: 10.1016/j.thromres.2018.11.010. Epub 2018 Nov 13.
7
Usefulness of plasma D-dimer level for monitoring development of distant organ metastasis in colorectal cancer patients after curative resection.血浆D-二聚体水平对监测结直肠癌患者根治性切除术后远处器官转移发展的有用性。
Cancer Manag Res. 2018 Oct 4;10:4203-4216. doi: 10.2147/CMAR.S177274. eCollection 2018.
8
What makes D-dimer assays suspicious-heterophilic antibodies?是什么导致D-二聚体检测出现可疑结果——嗜异性抗体?
J Clin Lab Anal. 2019 Feb;33(2):e22687. doi: 10.1002/jcla.22687. Epub 2018 Oct 15.
9
Cancer-associated ischemic stroke: A retrospective multicentre cohort study.癌症相关性缺血性卒中:一项回顾性多中心队列研究。
Thromb Res. 2018 May;165:33-37. doi: 10.1016/j.thromres.2018.03.011. Epub 2018 Mar 15.
10
Thrombosis in cancer patients: etiology, incidence, and management.癌症患者的血栓形成:病因、发病率及管理
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S178-S185. doi: 10.21037/cdt.2017.11.02.